Answers are grounded in this paper and cite their sources.
Post hoc analysis of five phase 3 trials found lower glucose variability linked to better HbA1c and mean daily glycemia in type 1 and type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Deborah Iodice (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: